P147 “What options are available for those not able to take current CFTR modulators?”: an answer hidden in plain sight?
Year: 2023
Type: article
Source: Journal of Cystic Fibrosis
Authors: T. Daniels, L.Y. Lai, S. Cameron, S. Dawson, S. Farrell, M. Hutchings, R.D. Sandler, J. Whitehouse, N. Withers, L. Baker, S.J. Bourke, M. Dooney, T. Saba, M. Pasteur, D. Waine, D. Derry, M. Allenby, K. Bateman, E. Pilkington, L. Warnock, H. Gledhill, S. Chapman, P. Galey, J. Choyce, N. Pickering, J. Dewar, G. Fitch, A. McGowan, R. Thomas, D. Shiferaw, C. Dowdell, H. Morgan, A. Anderson, T. Barnett, M. Thomas, W. Dale, L. Barlow, K. Ballinger, K. Lee, N. Robson, M.J. Wildman, Z.H. Hoo
Institutions: York St John University, University of Manchester, Sheffield Teaching Hospitals NHS Foundation Trust, Nottingham University Hospitals NHS Trust, University Hospitals Birmingham NHS Foundation Trust, Royal Devon University Healthcare NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Newcastle upon Tyne Hospitals NHS Foundation Trust, Blackpool Teaching Hospitals NHS Foundation Trust, Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, University Hospitals Plymouth NHS Trust, University Hospital Southampton NHS Foundation Trust, University Hospitals Bristol NHS Foundation Trust, Oxford University Hospitals NHS Trust, University Hospitals of North Midlands NHS Trust, University of Sheffield
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4379980099
